Huamin Wang

19PUBLICATIONS
214CO-AUTHORS
Molecular targetsCancer diagnosisPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 11, 2026
All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer.

|Apr 21, 2026
AI-Powered Deep Visual Proteomics Reveals Critical Molecular Transitions in Pancreatic Cancer Precursors.

|Apr 06, 2026
DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer.

Francesca Citron, Luca Cecchetto, Elisabetta Granato

|Jan 06, 2026
The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenocarcinoma.

Menna-T-Allah Shaheen, Sarah Dhebat, Kimal I Rajapakshe

|Dec 02, 2025
GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma.

Ziheng Chen, I-Lin Ho, Jintan Liu

|Dec 01, 2025
RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancer.

Warapen Treekitkarnmongkol, Hiroshi Katayama, Deivendran Sankaran

Pageof 4

Frequent Collaborators

8 joint publications

Anirban Maitra

7 joint publications

Haoqiang Ying

4 joint publications

Wantong Yao

4 joint publications

Ching-Fei Li